Healthcare
Pelage Pharmaceuticals Raises $120 Million for Revolutionary Hair Growth Therapy
Pelage Pharmaceuticals secured $120 million in Series B funding to advance its novel regenerative hair growth therapy PP405, which could transform treatment for millions suffering from hair loss by reactivating dormant hair follicle stem cells.
American Heart Association Launches Grant Program to Expand CPR Training in Schools
The American Heart Association is providing grants to 40 high school and college Heart Clubs nationwide to enhance CPR training and cardiac emergency preparedness, addressing the critical need for immediate response to out-of-hospital cardiac arrests that claim over 350,000 lives annually.
NFL Players Lead National CPR Awareness Campaign on World Restart a Heart Day
The American Heart Association and NFL have launched the 2025 Nation of Lifesavers initiative with 30 player ambassadors to address the critical need for CPR education, as immediate intervention can double or triple survival rates for sudden cardiac arrest victims.
University of Calgary Seeks 10,000 Toenail Samples for Radon Exposure and Lung Cancer Study
Canadian researchers are collecting toenail samples to develop better methods for measuring radon exposure and its connection to lung cancer risk, potentially enabling earlier diagnosis and treatment.
NeuroOne Expands Executive Leadership with Promotion of Emily Johns to Chief Administrative Officer
NeuroOne Medical Technologies has promoted Emily Johns to Chief Administrative Officer, signaling strategic focus on operational infrastructure as the company scales its neurological disorder treatment technologies.
Annovis Bio Secures $6 Million in Registered Direct Offering to Advance Neurodegenerative Disease Therapies
Annovis Bio has closed a $6 million registered direct offering to fund development of treatments for Alzheimer's and Parkinson's diseases, providing crucial capital for advancing late-stage clinical programs targeting neurodegeneration.
GeoVax Reports Positive Interim Results for Multi-Antigen COVID-19 Vaccine in Immunocompromised Patients
GeoVax Labs announced promising Phase 2 clinical trial results showing its multi-antigen COVID-19 vaccine candidate demonstrates strong safety and robust T-cell responses in immunocompromised patients, potentially addressing a critical gap in protection for vulnerable populations.
SouthernMED Pediatrics Expands Rock Hill Presence Through Sunshine Pediatrics Acquisition
SouthernMED Pediatrics has integrated Sunshine Pediatrics into its network, expanding pediatric healthcare access and services for Rock Hill families while maintaining the established practice's continuity of care.
Sweetgrass Pediatrics Expands Coastal Services with Acquisition of Inlet Pediatrics
Sweetgrass Pediatrics has acquired Inlet Pediatrics, expanding pediatric care access and resources for families in South Carolina's growing Grand Strand region while maintaining continuity with established healthcare providers.
American Heart Association Announces 2025 Paul 'Bear' Bryant Coach of the Year Award Watch List
The American Heart Association has revealed its 28-coach watch list for the 2025 Paul 'Bear' Bryant Coach of the Year Award, highlighting the intersection of athletic excellence and heart health awareness while honoring the legendary coach's legacy.
Izotropic Corp Advances AI-Powered Breast CT Technology to Address Radiation Concerns in Cancer Screening
Izotropic Corporation is developing an AI-native breast CT imaging system that addresses radiation exposure concerns while improving diagnostic accuracy through advanced technology integration.
Adageis CEO Details AI Platform's Role in Streamlining Value-Based Healthcare
Adageis CEO Shane Speirs discusses how the company's AI-powered platform is addressing administrative challenges in value-based care, supporting over 580,000 patients while making complex insurance and compliance processes more accessible to healthcare providers.
NanoViricides' Dual-Track Clinical Strategy for NV-387 Antiviral Drug Highlighted in Analyst Report
NanoViricides is advancing its broad-spectrum antiviral drug candidate NV-387 through a dual-track clinical development strategy targeting both MPox and respiratory viral infections, with potential implications for global pandemic preparedness and biodefense funding opportunities.
Alpha Cognition to Present at Spartan Capital Investor Conference, Highlighting Neurodegenerative Disease Treatments
Alpha Cognition's participation in the Spartan Capital Securities investor conference provides a platform to showcase its innovative treatments for Alzheimer's and cognitive impairment from traumatic brain injury, potentially attracting crucial investment for addressing unmet medical needs.
Humacyte Secures $60 Million in Oversubscribed Stock Offering to Advance Bioengineered Tissue Platform
Humacyte's successful $60 million capital raise provides critical funding to accelerate development of its universally implantable bioengineered human tissues, which have received multiple FDA designations and could transform treatment for vascular trauma, dialysis access, and other medical conditions.
The Center Hosts Exclusive Benefit Concert Featuring William Beckmann to Support Aging Adults in Texas Hill Country
The Center nonprofit organization is hosting an exclusive benefit concert featuring rising country artist William Beckmann to raise funds for essential programs supporting aging adults in Boerne and Kendall County, Texas.
Maryland Faces Multiple Policy Challenges as Insurance Carriers Exit Medicare Supplemental Market
Maryland seniors face uncertainty as insurance carriers withdraw Medicare supplemental plans while state Democrats launch a campaign to contest every political seat and lead a multi-state legal challenge against National Guard deployments.
Healthcare Marketing Summit Returns to Address Industry Challenges with Performance-Driven Strategies
Cardinal Digital Marketing's Scaling Up summit brings together healthcare marketing leaders to share growth strategies amid economic pressures and regulatory uncertainty, while introducing new industry awards.
SunKnowledge Emerges as Dominant Force in Healthcare Accounts Receivable Management
SunKnowledge Inc. has established itself as the leading provider of medical accounts receivable management, delivering significant improvements in collection rates, reimbursement speed, and operational efficiency for healthcare providers across all 50 states.
Lantern Pharma Advances Rare Pediatric Brain Cancer Treatment Using AI Platform
Lantern Pharma is preparing clinical trials for a rare pediatric brain cancer treatment using its AI-powered RADR platform, following positive FDA feedback on trial design and regulatory pathways.
Strawberry Fields REIT Targets $98 Billion Elderly Care Market Through Strategic Expansion
Strawberry Fields REIT is positioning itself to capitalize on the rapidly growing $49.29 billion elderly care market, which is projected to double by 2032 due to the aging baby boomer population.
University of Utah Enzyme Discovery Enables Programmable Peptide Modifications for Next-Generation Diabetes and Obesity Treatments
University of Utah researchers have developed an enzyme technology that can stabilize and enhance therapeutic peptides for diabetes and obesity treatments, with the innovation now advancing toward clinical development through spinout company Sethera Therapeutics.
FDA Approves One-Minute HIV Self-Test in Major Public Health Advancement
The FDA's approval of bioLytical's INSTI® HIV Self Test, which provides results in 60 seconds, represents a significant step toward reducing undiagnosed HIV cases and supporting national goals to end the HIV epidemic by making testing more accessible and private.
TransCode Therapeutics Advances Cancer Treatment with Successful Phase 1a Trial of TTX-MC138
TransCode Therapeutics has successfully completed Phase 1a clinical trials for TTX-MC138, an RNA-based cancer treatment targeting metastatic disease, showing promising safety results and disease stabilization in nearly half of patients, advancing to Phase 2 evaluation.
Trilliant Health Report Reveals Healthcare Costs Outpacing General Inflation, Creating Financial Strain for American Families
A new economic analysis shows U.S. healthcare costs have surged 54.5% since 2009, significantly outpacing general inflation and creating widespread medical debt burdens for families.
Soligenix Strengthens Medical Advisory Board to Advance HyBryte CTCL Treatment Through Phase 3 Development
Soligenix has updated its U.S. Medical Advisory Board with leading dermatologic and oncologic experts to guide the Phase 3 development and potential commercialization of HyBryte, a novel photodynamic therapy for cutaneous T-cell lymphoma that addresses significant unmet medical needs.
NeuroOne Expands Global Patent Portfolio with Key Approvals for Neurological Technology
NeuroOne Medical Technologies has strengthened its intellectual property position with new patent approvals in the US and Europe, signaling expanded opportunities for its neurological disorder treatment technologies.
ORGANA International Highlights Widespread Mineral Deficiencies in American Diets
ORGANA International reveals that modern food systems are creating significant nutrient gaps in American diets, offering natural mineral solutions to address deficiencies affecting energy, immunity, and overall wellness.
Women Face Significant Barriers in Cardiac Rehabilitation Access Despite Proven Health Benefits
A new scientific statement reveals women face substantial obstacles in accessing cardiac rehabilitation programs despite experiencing greater mortality reductions than men, highlighting urgent need for systemic changes to improve cardiovascular outcomes for female patients.
Orthopaedic Surgeon Dr. Ashish Patel Recognized as 2025 Castle Connolly Top Doctor
Dr. Ashish Patel's recognition as a Castle Connolly Top Doctor highlights the importance of peer-reviewed physician excellence and advanced spine surgery techniques that benefit patients with complex spinal conditions.